| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Jerzy Gumulka is Director at CNSP. Jerzy Gumulka's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $196K at current prices.
Historically, Jerzy Gumulka's trades have earned a below-average insider score of 25/100 across 3 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -85.7%.
Net of sales, the CNSP filings show accumulation of 43,006 shares.
Jerzy Gumulka has 8 Form 4 filings on record from June 2020 to November 2025, all as CNS Pharmaceuticals (CNSP), 2020–2025.
The 11 reported transactions were 8 option or other derivative awards and 3 open-market purchases.
Counted by filing, the open-market trades come to 3 purchases worth about $20K and no sales.
The largest open-market purchase was 33,333 shares of CNSP at an average $0.30 on February 1, 2024, about $10K. Twelve months later CNSP was down 99%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | CNSP Cns Pharmaceuticals, Inc. | Director | Buy | 33,333 | $0.30 | $9,999.90 | +344.6% | -13.7% | -99.2% | |
| Apr 19, 2023 | CNSP Cns Pharmaceuticals, Inc. | Director | Buy | 2,500 | $1.70 | $4,250.00 | +34.9% | +18.6% | -88.5% | |
| Apr 10, 2023 | CNSP Cns Pharmaceuticals, Inc. | Director | Buy | 7,173 | $0.74 | $5,308.02 | New | +224.3% | -69.4% |